Francesca Bonifazi
Francesca Bonifazi
Unknown affiliation
Verified email at unibo.it
TitleCited byYear
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
F Bonifazi, A de Vivo, G Rosti, F Guilhot, J Guilhot, E Trabacchi, ...
Blood 98 (10), 3074-3081, 2001
3832001
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kr÷ger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
2222016
A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo, G Martinelli, ...
Blood 99 (5), 1527-1535, 2002
2072002
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients
PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ...
haematologica 87 (12), 1258-1264, 2002
1832002
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin’s lymphoma: identification of prognostic factors predicting outcome
SP Robinson, A Sureda, C Canals, N Russell, D Caballero, A Bacigalupo, ...
haematologica 94 (2), 230-238, 2009
1702009
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
E Zino, G Frumento, S Marktel, MP Sormani, F Ficara, S Di Terlizzi, ...
Blood 103 (4), 1417-1424, 2004
1672004
Treatment of refractory chronic GVHD with rituximab: a GITMO study
F Zaja, A Bacigalupo, F Patriarca, M Stanzani, MT Van Lint, C Fili, ...
Bone marrow transplantation 40 (3), 273, 2007
1642007
Real-time quantitation of minimal residual disease in inv (16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
S Buonamici, E Ottaviani, N Testoni, V Montefusco, G Visani, F Bonifazi, ...
Blood 99 (2), 443-449, 2002
1602002
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologousá…
S Soverini, M Cavo, C Cellini, C Terragna, E Zamagni, D Ruggeri, ...
Blood 102 (5), 1588-1594, 2003
1452003
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant diseaseá…
P Corradini, A Dodero, L Farina, R Fanin, F Patriarca, R Miceli, ...
Leukemia 21 (11), 2316, 2007
1362007
Infliximab treatment for steroid-refractory acute graft-versus-host disease
F Patriarca, A Sperotto, D Damiani, G Morreale, F Bonifazi, A Olivieri, ...
haematologica 89 (11), 1352-1359, 2004
1352004
Long-Term Follow-Up of the Italian Trial of Interferon- Versus Conventional Chemotherapy in Chronic Myeloid Leukemia
Italian Cooperative Study Group on Chronic Myeloid Leukemia
Blood 92 (5), 1541-1548, 1998
1131998
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donorá…
A Dodero, F Spina, F Narni, F Patriarca, I Cavattoni, F Benedetti, F Ciceri, ...
Leukemia 26 (3), 520, 2012
1102012
Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network
GP Bagnara, L Bonsi, P Strippoli, F Bonifazi, R Tonelli, S D'Addato, ...
Journals of Gerontology-Biological Sciences and Medical Sciences 55 (2), B61, 2000
1092000
Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia
M Baccarani, G Martinelli, G Rosti, E Trabacchi, N Testoni, S Bassi, ...
Blood 104 (13), 4245-4251, 2004
1082004
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
G Rosti, G Martinelli, S Bassi, M Amabile, E Trabacchi, B Giannini, ...
Blood 103 (6), 2284-2290, 2004
1082004
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-doseá…
RM Lemoli, G Martinelli, E Zamagni, MR Motta, S Rizzi, C Terragna, ...
Blood 95 (7), 2234-2239, 2000
932000
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation.
MGP Della, A Gallý, A Bacigalupo, S Zibellini, M Bernardi, E Rizzo, ...
Journal of clinical oncology: official journal of the American Society ofá…, 2016
892016
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients
A Isidori, M Tani, F Bonifazi, P Zinzani, A Curti, MR Motta, S Rizzi, ...
Haematologica 90 (2), 225-231, 2005
792005
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients
PL Zinzani, M Tani, A Gabriele, V Poletti, V Stefoni, L Alinari, G Musuraca, ...
Leukemia & lymphoma 44 (5), 821-824, 2003
782003
The system can't perform the operation now. Try again later.
Articles 1–20